Aetna SmartRx Going Non-Commissionable for New Sales in 2023

SilverScript SmartRX and other PDPs

‍

Aetna looks forward to offering their current benchmark SilverScript Choice and SilverScript Plus plans in all 50 states and Washington, DC. SilverScript Plus is Aetna's richest product, offering a $0 deductible, $0 Tier 1/Tier 2 drugs during the initial coverage and gap phases, and slect insulins for $35/month at network pharmacies. Aetna is expecting SilverScript Choice plans to offer a $0 premium for your prospects receiving full Extra Help.

‍

The SilverScrip SmartRX plan is being renamed the SilverScropt SmartSaver plan and will not be commissionable for new sales. Please note that clients you previously enrolled in SilverScript SmartRX will remain enrolled in the SilverScropt SmartSaver in 2023, and you will continue to receive renewal commissions for these members.